In this online exclusive, Brady Haggstrom, IDBS, looks at the changing landscape of drug development and delivery, which is more and more outsourced nowadays, and how technology can help protect sensitive research data.
Digital pharma
Historically, the process for the development and delivery of new pharmaceutical drugs has operated behind closed-doors in a closed-off, singular facility.